[
  {
    "question": "Male patient from Africa illegal resident in Saudi who was in Jail and they brought him to the hospital as he didn\u2019t eat well for long time, in addition to complaint of headache and fever. No more details in the history due to language barrier. He was cachectic. CSF analysis showed elevated WBC (571, monoclonal cells predominant), high protein, and low glucose. Gram stain showed no organism. Which of the following is the most likely cause of his condition?",
    "option_a": "Plasmodium falciparum",
    "option_b": "Mycobacterium tuberculosis",
    "option_c": "Listeria monocytogens",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "Tuberculous meningitis is a form of extrapulmonary tuberculosis that affects the meninges. It is particularly common in individuals from endemic areas, malnourished populations, and incarcerated people. Mycobacterium tuberculosis gains access to the central nervous system via hematogenous spread from a pulmonary or extrapulmonary focus. In the subarachnoid space, the organism incites a granulomatous inflammatory reaction with a thick, gelatinous exudate, leading to obstruction of CSF flow and cerebral ischemia. The CSF profile typically shows lymphocytic pleocytosis, elevated protein, and low glucose. Patients often present with subacute symptoms including persistent headache, fever, altered mental status, and sometimes focal neurological deficits. The clinical picture of cachexia, history of incarceration, and being a resident from an endemic area (Africa) reinforces the likelihood of tuberculosis. The CSF findings further confirm a tubercular process. The diagnosis involves CSF analysis (showing lymphocytic pleocytosis, high protein, low glucose) and microbiological studies including acid-fast bacilli staining, culture, and PCR. Differential diagnoses include fungal meningitis, viral meningoencephalitis, and partially treated bacterial meningitis. A high index of suspicion is crucial in endemic populations. The first-line treatment is a standard antitubercular therapy regimen (typically a combination of isoniazid, rifampicin, pyrazinamide, and ethambutol) for an extended period (usually 9-12 months). Adjunctive corticosteroids are recommended to reduce inflammation and neurological damage. In pregnant and lactating patients, first-line antituberculous drugs are considered relatively safe, although pyrazinamide is used cautiously in pregnancy. Option B (Mycobacterium tuberculosis) is correct because the clinical scenario (cachexia, febrile illness, CSF findings of lymphocytic pleocytosis, high protein, low glucose, and negative Gram stain) is highly typical for tuberculous meningitis. Option A (Plasmodium falciparum) would typically present as cerebral malaria with a different CSF profile, and Option C (Listeria monocytogenes) generally affects the very young, elderly, or immunocompromised with a different CSF picture. 1. Always consider tuberculous meningitis in patients from endemic regions presenting with a subacute meningitic picture. 2. Early administration of corticosteroids alongside antituberculous therapy improves outcomes. 3. Delays in diagnosis can result in significant neurological morbidity. Recent WHO guidelines reiterate the importance of early diagnosis and initiation of combined antituberculous therapy along with corticosteroids to prevent complications. Newer molecular diagnostic tools such as GeneXpert MTB/RIF are also being increasingly utilized for rapid diagnosis.",
    "exam_year": "2023",
    "exam_type": "Part I"
  },
  {
    "question": "40-year-old man is seen in the emergency for evaluation of retinal hemorrhage, hepatosplenomegaly, headache, fever every 3 days and right arm weakness. On examination, his temperature is 38.10: He has some weakness of the right arm otherwise his examination is non-focal. He recently arrived from Africa. Which of the following is a highly diagnostic test?",
    "option_a": "Blood smear",
    "option_b": "CSF PCR",
    "option_c": "Brain MRI",
    "option_d": "Angiography",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Malaria is a parasitic disease endemic in many parts of Africa. The diagnostic gold standard is the examination of a blood smear to detect the presence of Plasmodium parasites. In malaria, Plasmodium parasites infect red blood cells, leading to cyclic fever and hemolysis. Severe forms, especially due to Plasmodium falciparum, can result in complications such as cerebral malaria, which may manifest with neurological deficits, retinal hemorrhages, and multi-organ involvement (including hepatosplenomegaly). The patient\u2019s cyclical fever (every 3 days), retinal hemorrhage, hepatosplenomegaly, and neurological findings (right arm weakness) are consistent with complications of malaria. The cyclical pattern reflects the parasite\u2019s life cycle, and the retinal hemorrhages can be a sign of severe infection. This clinical picture, especially in someone newly arrived from Africa, necessitates evaluation for malaria. The primary diagnostic test is a peripheral blood smear which can identify malarial parasites. Other diagnostic tools include rapid diagnostic tests (RDTs) based on antigen detection. Differential diagnoses include dengue fever (which typically has thrombocytopenia and rash), bacterial sepsis, and other hemorrhagic fevers, but the blood smear is key for malaria. First-line treatment for uncomplicated P. falciparum malaria involves artemisinin-based combination therapies (ACTs). In cases of severe malaria, intravenous artesunate is recommended. For pregnant and lactating women, treatment options are guided by gestational age and safety profiles; artesunate is generally preferred in the second and third trimesters, with careful monitoring in the first trimester. Option A (Blood smear) is correct as it is the most definitive and readily available test to diagnose malaria. Option B (CSF PCR) is more appropriate for diagnosing viral or fungal central nervous system infections; Option C (Brain MRI) and Option D (Angiography) are neither specific nor diagnostic for malaria. 1. A blood smear remains the gold standard in the diagnosis of malaria. 2. Cyclical fevers and organomegaly in a patient from Africa should prompt evaluation for malaria. 3. Rapid initiation of antimalarial therapy can be life-saving, particularly in severe cases. The latest guidelines from the WHO emphasize the utilization of blood smear and rapid diagnostic tests (RDTs) for confirmation of malaria and recommend ACTs as first-line therapy for P. falciparum malaria. There is ongoing research into newer diagnostic markers and treatment regimens to improve outcomes.",
    "exam_year": "2023",
    "exam_type": "Part I"
  },
  {
    "question": "Young Saudi male, he is studying in Africa, as he just came back with picture of radiculopathy, CSF showed eosinophilia. MRI showed hyperintense conus medullaris. Diagnosis of Schistosomiasis was confirmed by lab workup. What is the best treatment?",
    "option_a": "Praziquantel",
    "option_b": "Amphotericin B",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Schistosomiasis is a parasitic infection caused by trematode worms of the genus Schistosoma. Neuroschistosomiasis, although less common, can affect the spinal cord leading to radiculopathy and myelopathy, as seen in this patient. After cercarial penetration through the skin, Schistosoma parasites mature and migrate through the bloodstream. In some cases, eggs become lodged in the central nervous system, particularly in the spinal cord, provoking an eosinophilic inflammatory response and granuloma formation. This inflammatory process can result in hyperintense lesions seen on MRI, especially affecting the conus medullaris. The patient\u2019s presentation with radiculopathy, CSF eosinophilia, and MRI findings of a hyperintense conus medullaris is highly suggestive of neuroschistosomiasis. The history of recent travel to Africa further supports exposure to endemic Schistosoma species. Diagnosis is based on a combination of clinical findings, imaging (MRI), CSF analysis (with eosinophilia), and confirmation with serological tests or identification of Schistosoma eggs. Differential diagnoses include other causes of eosinophilic meningitis such as parasitic infections (e.g., Angiostrongylus cantonensis) or allergic inflammatory conditions. The treatment of choice is Praziquantel, which is effective against the adult worms. In neuroschistosomiasis, corticosteroids are often administered concurrently to reduce the inflammatory response associated with the dying parasites. In pregnant and lactating women, Praziquantel is generally considered safe (Category B), although the decision to treat should weigh potential benefits against any possible risks. Option A (Praziquantel) is correct because it is the recommended first-line treatment for schistosomiasis. Option B (Amphotericin B) is an antifungal agent and is not indicated for a parasitic infection like schistosomiasis. The other options are not provided but are irrelevant to the management of schistosomiasis. 1. Schistosomiasis should be suspected in patients with eosinophilia and neurological symptoms returning from endemic areas. 2. Praziquantel is the cornerstone of therapy, often used in combination with steroids in neuroschistosomiasis. 3. Early recognition and treatment are important to prevent irreversible neurological damage. Recent research supports the efficacy of Praziquantel as the frontline agent in treating schistosomiasis across various manifestations. Guidelines from the WHO endorse its use even in special populations such as pregnant and lactating women, with adjunctive corticosteroid therapy recommended for neuroschistosomiasis to mitigate inflammatory damage.",
    "exam_year": "2023",
    "exam_type": "Part I"
  },
  {
    "question": "WOTF is the most common cause of sporadic fatal meningoencephalitis ?",
    "option_a": "HSV1",
    "option_b": "EBV",
    "option_c": "CMV",
    "option_d": "HPV",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Herpes simplex virus type 1 (HSV-1) is well recognized as the most common cause of sporadic fatal meningoencephalitis. This condition typically presents in adults with rapid progression and focal neurological signs due to preferential involvement of the temporal lobes. HSV-1 enters the central nervous system, often via retrograde transport along the trigeminal nerve, leading to necrotizing encephalitis primarily affecting the temporal and inferior frontal lobes. The viral infection causes hemorrhagic necrosis and inflammation, which results in edema, neuronal loss, and potentially fatal brain injury. Patients usually present with acute onset fever, headache, altered mental status, seizures, and focal neurological deficits, particularly involving memory and behavioral changes. Early recognition is critical given the high mortality rate without prompt antiviral therapy. Key diagnostic steps include lumbar puncture for cerebrospinal fluid (CSF) analysis with PCR testing for HSV DNA, which is the diagnostic gold standard. Neuroimaging, particularly MRI with involvement of the temporal lobes, supports the diagnosis. Differential diagnoses include other forms of encephalitis (e.g., varicella-zoster, arboviruses), autoimmune encephalitis, and bacterial meningitis. The standard of care for HSV-1 encephalitis is prompt initiation of high-dose intravenous acyclovir, which significantly improves outcomes if started early. In pregnant and lactating women, acyclovir is considered safe (usually classified as FDA Category B) and should be administered without delay if HSV encephalitis is suspected. Supportive care and management of raised intracranial pressure are also important. In neonates with HSV encephalitis, different dosing (usually based on weight) and a longer treatment course are recommended. Option A (HSV-1) is correct because it is the most common cause of sporadic fatal meningoencephalitis. EBV and CMV can affect the CNS but are not typically associated with an encephalitis of this acute, fulminant nature in immunocompetent hosts. HPV is unrelated to central nervous system infections. Early diagnosis and treatment with acyclovir are essential to reducing morbidity and mortality. Always consider HSV-1 in cases of acute encephalitis with temporal lobe involvement on imaging. Do not delay antiviral therapy while awaiting confirmatory PCR results. Recent guidelines emphasize early lumbar puncture and initiation of acyclovir therapy in suspected cases of HSV encephalitis. Clinical outcomes have significantly improved with prompt antiviral treatment, and current research continues to support this approach in both typical and special populations, including pregnant and lactating women.",
    "exam_year": "2023",
    "exam_type": "Part I"
  },
  {
    "question": "Young male presented with headache and fever. CT brain was normal. LP decided to be done by the intern. CSF analysis showed WBCs 48, RBCs 780, normal protein, and glucose. What of the following is the most likely interpretation?",
    "option_a": "Traumatic tap",
    "option_b": "Viral meningitis",
    "option_c": "Bacterial meningitis",
    "option_d": "Subarachnoid hemorrhage",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "This case involves a young male with headache and fever. In evaluating CSF studies, viral meningitis typically shows a mild to moderate lymphocytic pleocytosis (often in the range of 10\u2013500 cells/\u03bcL), with normal or slightly elevated protein and normal glucose levels. The presence of some red blood cells (RBCs) can occur if the lumbar puncture is traumatic. Here, although 780 RBCs/\u03bcL are noted, the number is not high enough to suggest a hemorrhagic event and is more consistent with a contamination artifact during the procedure. Viral meningitis occurs when viruses such as enteroviruses, herpes simplex virus (HSV), or other neurotropic viruses invade the meninges, triggering a predominantly lymphocytic inflammatory response. The meningeal inflammation results in mild pleocytosis, while the blood\u2013brain barrier typically remains intact enough to keep protein and glucose levels near normal. RBCs are not a feature of the disease itself but can be introduced inadvertently as a result of a traumatic tap. The patient\u2019s symptoms of headache and fever are characteristic of meningitis with a viral etiology. Bacterial meningitis would be expected to present with a high WBC count (often in the thousands), predominantly neutrophils, elevated protein, and low glucose. Subarachnoid hemorrhage tends to produce markedly higher RBC counts (often in the thousands) and is typically not associated with fever. The key differential diagnoses include viral meningitis, bacterial meningitis, and a traumatic tap artifact. In this case, the normal protein and glucose, along with a modest WBC count, favor a viral process. Additionally, if there were a traumatic tap, one would expect a lower ratio of WBCs to RBCs (given that normal peripheral blood has roughly 1 WBC per 700\u20131000 RBCs), but the observed WBC count (48) far exceeds what would be expected solely from peripheral blood contamination (which might contribute only 1\u20132 cells). This supports the interpretation of a true inflammatory process consistent with viral meningitis. The management of viral meningitis is primarily supportive, including analgesia, hydration, and rest. Specific antiviral agents (e.g., acyclovir) are reserved for cases where herpes simplex virus (HSV) is suspected. For pregnant or lactating patients who require antiviral therapy, acyclovir is considered relatively safe and is supported by current guidelines. It is also critical to rule out bacterial causes with appropriate cultures and to consider repeat LPs or additional imaging if the clinical status worsens. Option A (Traumatic tap) could account for some RBC presence but does not explain the level of WBC elevation. Option C (Bacterial meningitis) generally presents with a markedly higher WBC count (predominantly neutrophils), elevated protein, and decreased glucose, which are not seen here. Option D (Subarachnoid hemorrhage) typically features a substantially higher RBC count with a consistent number across tubes and often xanthochromia, and it is not associated with fever. Thus, Option B (Viral meningitis) best fits the complete clinical and CSF profile. \u2022 When interpreting CSF results, consider both the absolute counts and the ratio between WBCs and RBCs to distinguish a traumatic tap from true pathology.  Recent clinical guidelines emphasize supportive management for viral meningitis and the judicious use of antiviral therapy when HSV is suspected. In pregnancy and lactation, acyclovir remains the preferred antiviral when indicated due to its favorable safety profile. The diagnostic approach continues to stress careful procedure technique during lumbar puncture to minimize artifacts such as traumatic taps.",
    "exam_year": "2023",
    "exam_type": "Part I"
  },
  {
    "question": "Patient with meningitis, came from Alhaj, found to have meningococcal meningitis. What is the appropriate prophylactic antibiotic for the close contacts?",
    "option_a": "Ciprofloxacin",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Meningococcal meningitis is a medical emergency caused by Neisseria meningitidis. Close contacts are at high risk of infection due to droplet transmission, and prophylactic antibiotic therapy is indicated to prevent secondary cases. Neisseria meningitidis colonizes the nasopharyngeal mucosa and can invade the bloodstream and meninges. Prophylaxis works by eradicating nasopharyngeal carriage among close contacts, thereby interrupting transmission. Individuals in close contact with a patient (e.g., household members, classmates, or anyone with intimate contact) are at increased risk and should be provided antibiotic prophylaxis promptly to prevent potential outbreaks. Diagnosis of meningococcal meningitis is confirmed by cerebrospinal fluid analysis and culture or PCR testing. Once confirmed, identifying at-risk contacts and administering prophylaxis is crucial. For prophylaxis in nonpregnant adults, a single oral dose of ciprofloxacin (usually 500 mg) is acceptable and effective. Alternative regimens include rifampin or intramuscular ceftriaxone. Notably, for pregnant or lactating women, ciprofloxacin should be avoided and ceftriaxone is preferred. These recommendations are in line with current CDC guidelines. Option A, Ciprofloxacin, is an appropriate first-line prophylactic choice for close contacts provided they are not pregnant. The alternatives (e.g., rifampin or ceftriaxone) would be considered in specific circumstances such as pregnancy. Given the marked answer and context, Option A is justified. Always assess the pregnancy/lactation status of contacts before choosing a prophylactic regimen. Ciprofloxacin is contraindicated in pregnant and lactating women due to potential cartilage toxicity, and ceftriaxone is preferred in these cases. Current guidelines from the CDC and other public health authorities support the use of oral ciprofloxacin as a single-dose regimen for prophylaxis in nonpregnant adults exposed to meningococcal meningitis. This strategy is effective in rapidly reducing nasopharyngeal carriage of Neisseria meningitidis.",
    "exam_year": "2023",
    "exam_type": "Part I"
  },
  {
    "question": "A 70-year-old male brought to ER with fever confusion and drowsiness. CSF analysis showed bacterial infection. What is the appropriate treatment?",
    "option_a": "Vancomycin, Ceftriaxone and Ampicillin",
    "option_b": "Vancomycin and Ceftriaxone",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Bacterial meningitis in elderly patients requires broad-spectrum antimicrobial coverage, especially to cover Listeria monocytogenes, which is more common in individuals older than 50 years. The empirical treatment involves a combination of antibiotics to cover the most frequent pathogens such as Streptococcus pneumoniae, Neisseria meningitidis, and Listeria monocytogenes. Bacterial meningitis is characterized by infection of the meninges, leading to inflammation and subsequent neurological impairment. The bacteria invade the subarachnoid space, triggering an inflammatory response that results in blood-brain barrier disruption, cerebral edema, and increased intracranial pressure. The patient, a 70-year-old male presenting with fever, confusion, and drowsiness, fits the classic clinical profile of bacterial meningitis in the elderly. In this age group, the risk for Listeria infection is heightened, making it critical to include agents that target this pathogen. The diagnosis is supported by CSF analysis showing signs of bacterial infection such as increased white blood cell count (predominantly neutrophils), low glucose levels, and elevated protein levels. Differential diagnoses include viral meningitis and tuberculous meningitis, but the CSF profile here confirms a bacterial etiology. According to the latest guidelines, empirical treatment for suspected bacterial meningitis in patients older than 50 should include Vancomycin (to cover resistant Streptococcus pneumoniae), Ceftriaxone (broad-spectrum gram-negative and gram-positive coverage), and Ampicillin (for Listeria). In pregnancy and lactation, Ampicillin is considered safe, while careful consideration should be given to the safety profiles of Vancomycin and Ceftriaxone, all of which are typically used when benefits outweigh risks. Option A (Vancomycin, Ceftriaxone, and Ampicillin) is correct because it comprehensively covers the likely pathogens in an elderly patient. Option B omits Ampicillin, thereby not covering Listeria monocytogenes, which is a significant risk in this age group. Options C and D are not provided and thus do not contribute to the decision-making process. Empirical therapy for bacterial meningitis should not be delayed given the rapid progression of the disease. In elderly patients, always include coverage for Listeria monocytogenes with Ampicillin. Awareness of local resistance patterns and individual patient factors (such as allergies and renal function) is essential when selecting antibiotics. Recent clinical guidelines, including those from the Infectious Diseases Society of America (IDSA), continue to support the use of a triple regimen (Vancomycin, Ceftriaxone, and Ampicillin) in patients over 50 years with suspected bacterial meningitis. Clinical studies affirm that this approach improves outcomes by ensuring comprehensive coverage while awaiting culture results.",
    "exam_year": "2023",
    "exam_type": "Part I"
  },
  {
    "question": "Healthy came from hiking in USA with radiculopathy: CSF: WBC: 22 (lymphocytes 90%), protein high, glucose normal:",
    "option_a": "Lyme",
    "option_b": "Aspergillosis",
    "option_c": "TB",
    "option_d": "Pneumococcal",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "This case describes a patient with radiculopathy following a hiking trip in the USA. Exposure to tick\u2010infested areas is a classic trigger for Lyme disease, and Lyme neuroborreliosis can present with radicular pain (Bannwarth syndrome). The CSF findings of a mild lymphocytic pleocytosis (22 cells with 90% lymphocytes), slightly elevated protein, and normal glucose are typical for neuroborreliosis. Lyme disease is caused by the spirochete Borrelia burgdorferi, transmitted by Ixodes ticks. Once infected, the bacteria may disseminate to the nervous system causing inflammation of the meninges and nerve roots. This inflammatory reaction accounts for the lymphocyte\u2010predominant CSF pattern and modest protein elevation without glucose consumption, which differentiates it from bacterial meningitis. Patients often present with radicular pain, which can be accompanied by other neurological signs such as facial nerve palsy. The history of recent outdoor activities in endemic areas (USA) is an essential clinical clue. The CSF profile supports a diagnosis of Lyme neuroborreliosis rather than other causes of meningitis. Differential diagnoses include tuberculous meningitis (typically shows a much higher cell count, low glucose, and very high protein), fungal meningitis (often seen in immunocompromised patients with low glucose), and acute bacterial (e.g., pneumococcal) meningitis (with neutrophilic pleocytosis and low glucose). Lyme disease is further confirmed by serologic testing and sometimes intrathecal antibody detection. The first-line treatment for Lyme neuroborreliosis is typically intravenous ceftriaxone, although oral doxycycline may be used in certain early cases. In pregnant or lactating patients, doxycycline is contraindicated; hence, amoxicillin or ceftriaxone becomes the treatment of choice. The current guidelines emphasize early recognition and prompt antibiotic therapy to prevent long-term neurological complications. Option A (Lyme) is correct based on the patient\u2019s history, CSF findings, and geographic exposure. Option B (Aspergillosis) usually affects immunocompromised hosts and presents with a different CSF profile. Option C (TB) typically shows a more pronounced lymphocytic pleocytosis with low glucose levels. Option D (Pneumococcal) is associated with a neutrophil-predominant CSF and decreased glucose. 1. A history of outdoor exposure in endemic areas is a key clue for Lyme disease. 2. CSF in neuroborreliosis usually shows a mild lymphocytic pleocytosis with normal glucose. 3. Early treatment with appropriate antibiotics significantly improves outcomes. Recent guidelines continue to support the use of ceftriaxone for neuroborreliosis, with multiple studies confirming that early intervention reduces long-term neurological sequelae. Updated serologic and CSF antibody testing aids in the rapid diagnosis of Lyme neuroborreliosis.",
    "exam_year": "2024",
    "exam_type": "Part I"
  },
  {
    "question": "HIV Patient came with blurry vision there is two pic one with contrast other without, it was non-enhancing, management.",
    "option_a": "PLEX",
    "option_b": "HAART",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "In this HIV-positive patient with blurry vision, the MRI findings \u2013 specifically the lack of enhancement with contrast \u2013 point toward a non-inflammatory demyelinating process. This radiologic pattern is most consistent with Progressive Multifocal Leukoencephalopathy (PML), a demyelinating disease associated with JC virus reactivation in immunocompromised patients. PML is caused by reactivation of the JC virus in the context of severe immunosuppression, such as that seen in untreated or advanced HIV/AIDS. The virus infects oligodendrocytes leading to demyelination in the white matter, which explains the non-enhancing lesions seen on MRI. PML typically presents with a subacute onset of neurological deficits, including visual changes, cognitive dysfunction, and motor weakness. Blurry vision can be a manifestation of parieto-occipital white matter involvement. The absence of contrast enhancement is a useful distinguishing feature from other infectious or neoplastic processes in the CNS. Differential diagnoses include primary CNS lymphoma (which usually shows contrast enhancement), toxoplasmosis (which typically manifests with ring-enhancing lesions), and other demyelinating conditions. A CSF analysis testing for JC virus DNA via PCR is commonly used to support the diagnosis of PML. The mainstay of treatment for PML in HIV patients is restoring immune function with Highly Active Antiretroviral Therapy (HAART). There is no effective direct antiviral therapy for JC virus. In pregnant patients, HAART is also indicated with appropriate regimen adjustments to minimize teratogenicity. Lactating women are managed similarly, with attention to the safety of the chosen antiretroviral agents during breastfeeding. Option A (PLEX) is not indicated in the management of PML. Option B (HAART) is correct, as optimizing antiretroviral therapy remains the only proven management strategy for PML. Options C and D are not provided, and no other management strategies are effective for PML. 1. PML lesions are typically non-enhancing on MRI, which helps differentiate them from CNS lymphoma and toxoplasmosis. 2. Immune reconstitution with HAART is the only proven treatment for PML in HIV patients. 3. Early recognition of PML is critical, as delayed initiation of HAART is associated with poor outcomes. Recent research reinforces that the optimization of HAART improves survival in PML. No specific anti-JC virus therapies have been successfully validated, and current clinical guidelines continue to focus on immune reconstitution.",
    "exam_year": "2024",
    "exam_type": "Part I"
  },
  {
    "question": "Heroin abuser, severe back pain and tenderness, fever what is the most likely organism found.",
    "option_a": "Streptococcus",
    "option_b": "Staphylococcus aureus",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "In an intravenous drug user such as a heroin abuser presenting with severe back pain, tenderness, and fever, the clinical picture is highly suggestive of an infectious process such as vertebral osteomyelitis or epidural abscess. Staphylococcus aureus is the most common organism implicated in these cases. Hematogenous spread of Staphylococcus aureus is common among IV drug users due to repeated injections and potential for bacteremia. The bacteria localize in the vertebral bodies, causing infection that may extend into adjacent structures and form an epidural abscess, leading to severe pain and possible neurological compromise. Patients typically present acutely with localized back pain, tenderness over the affected vertebra, and systemic symptoms such as fever. The risk of neurological deficits increases if an epidural abscess compresses the spinal cord or nerve roots. Differentials include tuberculosis (Pott's disease), which tends to have a more insidious onset and different radiographic findings, and infections caused by Gram-negative organisms. MRI is the imaging modality of choice, and blood cultures or biopsy can help confirm Staphylococcus aureus infection. The initial treatment involves prompt intravenous antibiotic therapy targeted against Staphylococcus aureus, with MRSA coverage (e.g., vancomycin) if risk factors are present. Treatment duration usually spans 6 weeks or longer. In pregnant patients, antibiotic choices must consider fetal safety (agents like vancomycin or first-generation cephalosporins can be used after reviewing safety data) and similar considerations apply during lactation. Option A (Streptococcus) is less commonly implicated in vertebral osteomyelitis among IV drug users. Option B (Staphylococcus aureus) is the correct answer due to its high prevalence and association with IV drug use. Options C and D are not provided. 1. IV drug use is a significant risk factor for Staphylococcus aureus bacteremia and subsequent vertebral osteomyelitis or epidural abscess. 2. Early imaging with MRI is critical for diagnosis. 3. Prolonged, targeted antibiotic therapy is essential to prevent complications. Recent clinical guidelines emphasize the high incidence of MRSA in IV drug users and recommend early MRI and culture-guided antibiotic therapy. Ongoing studies continue to refine the duration of therapy and indications for surgical intervention.",
    "exam_year": "2024",
    "exam_type": "Part I"
  },
  {
    "question": "Patient HIV, pain radiation to back, MRI spine negative, CSF negative.",
    "option_a": "HZV",
    "option_b": "CMV",
    "option_c": "HIV Myelitis",
    "option_d": "vacuolar myelopathy",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Neuro-infectious",
    "explanation": "In HIV patients presenting with myelopathic symptoms such as pain with radiation to the back, a normal MRI and unremarkable CSF evaluation point toward a non-inflammatory, degenerative process. Vacuolar myelopathy is a well-recognized complication in advanced HIV infection and is characterized by such findings. Vacuolar myelopathy arises from direct HIV-mediated injury or the chronic effects of immune activation leading to demyelination and vacuole formation within the spinal cord, predominantly affecting the dorsal columns and lateral corticospinal tracts. This results in a slowly progressive myelopathy without significant inflammatory CSF changes or MRI lesions. Clinically, patients may experience subtle back pain, progressive spastic paraparesis, gait disturbances, and proprioceptive deficits. Unlike acute infectious myelitis (e.g., due to HZV or CMV), vacuolar myelopathy unfolds gradually and does not produce the typical inflammatory CSF findings or contrast-enhancing lesions on MRI. Differential diagnoses include Herpes Zoster Virus (HZV) radiculopathy, CMV myelitis, and acute HIV myelitis. HZV usually presents with a dermatomal rash and may show nerve root enhancement on imaging, while CMV myelitis is often accompanied by abnormal CSF studies and MRI abnormalities. HIV myelitis, though a possibility, would typically show some MRI signal changes. The negative imaging and CSF profile strongly favors vacuolar myelopathy. There is no definitive treatment for vacuolar myelopathy apart from optimizing antiretroviral therapy (HAART) to prevent further progression. Symptomatic management, including physical therapy and spasticity control, is recommended. In pregnant and lactating patients, HAART remains the cornerstone of management with careful selection of agents to ensure fetal and neonatal safety. Option A (HZV) is incorrect because Herpes Zoster typically presents with a vesicular rash, may show MRI abnormalities, and usually has inflammatory CSF findings. Option B (CMV) also tends to produce abnormal CSF and MRI findings. Option C (HIV Myelitis) is less likely because it usually shows more acute changes on MRI. Option D (vacuolar myelopathy) is correct given the chronic nature of the condition, negative imaging, and CSF. 1. Vacuolar myelopathy is one of the most common causes of spinal cord dysfunction in patients with advanced HIV. 2. It is typically non-inflammatory, with normal CSF studies and minimal MRI findings in early stages. 3. Optimizing HAART is the only available intervention to slow disease progression. Recent studies and HIV management guidelines underscore the importance of early and sustained HAART to mitigate neurological complications such as vacuolar myelopathy. While research continues into neuroprotective strategies, current standard of care remains focused on immune reconstitution.",
    "exam_year": "2024",
    "exam_type": "Part I"
  },
  {
    "question": "HIV patient came to the clinic with single ring enhancing lesion in brain next.",
    "option_a": "CSF",
    "option_b": "Start Antibiotics",
    "option_c": "Toxoplasmois management",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Neuro-infectious",
    "explanation": "In HIV\u2010infected patients, ring\u2010enhancing brain lesions are most commonly due to toxoplasmosis. Even though primary CNS lymphoma is an important differential, the empiric management for a typical radiographic lesion is to treat for toxoplasmosis first. Reactivation of latent Toxoplasma gondii in immunocompromised patients causes focal brain abscesses. The necrotic center with surrounding inflammatory cells produces the characteristic ring enhancement on imaging. This process is driven by the inability of a weak immune system to contain latent infection. Patients typically present with headache, confusion, or focal neurological deficits. In advanced HIV, toxoplasmosis is the most frequent cause of intracerebral mass lesions. Empiric treatment often leads to clinical and radiographic improvement, with failure of response prompting further evaluation (e.g., biopsy for lymphoma). The differential includes primary CNS lymphoma and other infectious causes. Guidelines recommend starting an empiric regimen\u2014usually with pyrimethamine, sulfadiazine, and leucovorin\u2014and re-imaging after 10\u201314 days. CSF analysis and advanced imaging (MRI spectroscopy) may be employed if the response is equivocal. According to current guidelines, the first-line management is an empiric anti-toxoplasmosis regimen: pyrimethamine plus sulfadiazine and folinic acid (leucovorin). In pregnant patients, spiramycin is often preferred in the first trimester to avoid fetal toxicity. Lactating mothers need counseling on medication safety and possible alternatives. Option A (CSF analysis) is not the immediate next step because the classic imaging finding in an HIV patient leads directly to empiric toxoplasmosis treatment. Option B (\u2018Start Antibiotics\u2019) is too vague since the specific anti-toxoplasmosis regimen is required. Option C (Toxoplasmosis management) is correct, and Option D is blank. \u2022 In HIV patients with ring\u2010enhancing lesions, toxoplasmosis is the most common cause. \u2022 An empiric trial of anti\u2010toxoplasmosis therapy is recommended before invasive testing. \u2022 Lack of improvement after 2 weeks should raise suspicion for primary CNS lymphoma. Recent guidelines reaffirm the strategy of an empiric trial for cerebral toxoplasmosis, emphasizing early treatment to avoid unnecessary delays. Advanced imaging techniques continue to refine the differentiation between toxoplasmosis and lymphoma.",
    "exam_year": "2024",
    "exam_type": "Part I"
  },
  {
    "question": "Pic of ribboning. what is the most likely.",
    "option_a": "Prion disease",
    "option_b": "",
    "option_c": "(Toxoplasmosis management) is correct, and Option D is blank.",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "In HIV\u2010infected patients, ring\u2010enhancing brain lesions are most commonly due to toxoplasmosis. Even though primary CNS lymphoma is an important differential, the empiric management for a typical radiographic lesion is to treat for toxoplasmosis first. Reactivation of latent Toxoplasma gondii in immunocompromised patients causes focal brain abscesses. The necrotic center with surrounding inflammatory cells produces the characteristic ring enhancement on imaging. This process is driven by the inability of a weak immune system to contain latent infection. Patients typically present with headache, confusion, or focal neurological deficits. In advanced HIV, toxoplasmosis is the most frequent cause of intracerebral mass lesions. Empiric treatment often leads to clinical and radiographic improvement, with failure of response prompting further evaluation (e.g., biopsy for lymphoma). The differential includes primary CNS lymphoma and other infectious causes. Guidelines recommend starting an empiric regimen\u2014usually with pyrimethamine, sulfadiazine, and leucovorin\u2014and re-imaging after 10\u201314 days. CSF analysis and advanced imaging (MRI spectroscopy) may be employed if the response is equivocal. According to current guidelines, the first-line management is an empiric anti-toxoplasmosis regimen: pyrimethamine plus sulfadiazine and folinic acid (leucovorin). In pregnant patients, spiramycin is often preferred in the first trimester to avoid fetal toxicity. Lactating mothers need counseling on medication safety and possible alternatives. Option A (CSF analysis) is not the immediate next step because the classic imaging finding in an HIV patient leads directly to empiric toxoplasmosis treatment. Option B (\u2018Start Antibiotics\u2019) is too vague since the specific anti-toxoplasmosis regimen is required. Option C (Toxoplasmosis management) is correct, and Option D is blank. \u2022 In HIV patients with ring\u2010enhancing lesions, toxoplasmosis is the most common cause. \u2022 An empiric trial of anti\u2010toxoplasmosis therapy is recommended before invasive testing. \u2022 Lack of improvement after 2 weeks should raise suspicion for primary CNS lymphoma. Recent guidelines reaffirm the strategy of an empiric trial for cerebral toxoplasmosis, emphasizing early treatment to avoid unnecessary delays. Advanced imaging techniques continue to refine the differentiation between toxoplasmosis and lymphoma.",
    "exam_year": "2024",
    "exam_type": "Part I"
  },
  {
    "question": "Best management of Neuro-brucellosis.",
    "option_a": "Doxycycline",
    "option_b": "Ceftriaxone",
    "option_c": "(Toxoplasmosis management) is correct, and Option D is blank.",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "In HIV\u2010infected patients, ring\u2010enhancing brain lesions are most commonly due to toxoplasmosis. Even though primary CNS lymphoma is an important differential, the empiric management for a typical radiographic lesion is to treat for toxoplasmosis first. Reactivation of latent Toxoplasma gondii in immunocompromised patients causes focal brain abscesses. The necrotic center with surrounding inflammatory cells produces the characteristic ring enhancement on imaging. This process is driven by the inability of a weak immune system to contain latent infection. Patients typically present with headache, confusion, or focal neurological deficits. In advanced HIV, toxoplasmosis is the most frequent cause of intracerebral mass lesions. Empiric treatment often leads to clinical and radiographic improvement, with failure of response prompting further evaluation (e.g., biopsy for lymphoma). The differential includes primary CNS lymphoma and other infectious causes. Guidelines recommend starting an empiric regimen\u2014usually with pyrimethamine, sulfadiazine, and leucovorin\u2014and re-imaging after 10\u201314 days. CSF analysis and advanced imaging (MRI spectroscopy) may be employed if the response is equivocal. According to current guidelines, the first-line management is an empiric anti-toxoplasmosis regimen: pyrimethamine plus sulfadiazine and folinic acid (leucovorin). In pregnant patients, spiramycin is often preferred in the first trimester to avoid fetal toxicity. Lactating mothers need counseling on medication safety and possible alternatives. Option A (CSF analysis) is not the immediate next step because the classic imaging finding in an HIV patient leads directly to empiric toxoplasmosis treatment. Option B (\u2018Start Antibiotics\u2019) is too vague since the specific anti-toxoplasmosis regimen is required. Option C (Toxoplasmosis management) is correct, and Option D is blank. \u2022 In HIV patients with ring\u2010enhancing lesions, toxoplasmosis is the most common cause. \u2022 An empiric trial of anti\u2010toxoplasmosis therapy is recommended before invasive testing. \u2022 Lack of improvement after 2 weeks should raise suspicion for primary CNS lymphoma. Recent guidelines reaffirm the strategy of an empiric trial for cerebral toxoplasmosis, emphasizing early treatment to avoid unnecessary delays. Advanced imaging techniques continue to refine the differentiation between toxoplasmosis and lymphoma.",
    "exam_year": "2024",
    "exam_type": "Part I"
  },
  {
    "question": "Patient come with personality change headache, increase thirsty for months, MRI show hyperintensity in cortical subcortical and cerebellum area with CSF show low gluc and high protein(58) and cell count with lymph predominance what the cause?",
    "option_a": "TB meningoencephalitis",
    "option_b": "Neurosarcoidosis",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Neuro-infectious",
    "explanation": "The patient\u2019s presentation of personality changes and headache along with increased thirst over several months points to a chronic neuroinflammatory process. The increased thirst suggests involvement of the hypothalamic-pituitary axis (i.e., central diabetes insipidus), which is a known manifestation of neurosarcoidosis. The CSF profile showing low glucose, elevated protein, and lymphocytic predominance further supports a granulomatous process, which is in keeping with neurosarcoidosis rather than an acute infectious process. Neurosarcoidosis involves the formation of non-caseating granulomas within the CNS. When granulomatous inflammation affects the hypothalamus or pituitary, patients may develop endocrine abnormalities such as diabetes insipidus (presenting as increased thirst). Additionally, parenchymal involvement by granulomas can produce multifocal hyperintense lesions on MRI in cortical, subcortical, and cerebellar regions. In this case, the combination of neuropsychiatric symptoms (personality changes, headache), MRI findings of multifocal hyperintensities, and endocrine dysfunction (increased thirst due to central diabetes insipidus) aligns with neurosarcoidosis. Although tuberculous (TB) meningoencephalitis may yield similar CSF findings (low glucose, high protein, lymphocytic predominance), it typically presents with basal meningeal involvement and lacks the classic endocrine features seen here. Key differentials include TB meningoencephalitis, neurosarcoidosis, and less commonly fungal meningitis. TB is known for a basilar meningeal pattern and may not cause diabetes insipidus. The diagnostic workup should include serum angiotensin converting enzyme (ACE) levels, chest imaging for systemic sarcoidosis, and possibly tissue biopsy to confirm granulomatous inflammation. Endocrine evaluation (e.g., water deprivation test) may be needed to assess for diabetes insipidus. The first-line therapy for neurosarcoidosis is high-dose corticosteroids, which help reduce inflammation and prevent permanent neurological deficits. For patients who are pregnant or lactating, corticosteroids remain the mainstay treatment; however, it is essential to monitor for potential side effects such as gestational diabetes and fetal growth issues. If steroid-sparing immunosuppressants (e.g., methotrexate or azathioprine) are required, their use should be carefully weighed with regards to current pregnancy and lactation safety guidelines. Option A (TB meningoencephalitis) is a well-known cause of chronic meningitis with similar CSF findings, but the presence of central diabetes insipidus (manifested as increased thirst) and the distribution of MRI hyperintensities favor neurosarcoidosis (Option B). The incomplete options (C and D) make option B the most plausible and correct choice. \u2022 Always consider neurosarcoidosis when a patient exhibits unexplained neuropsychiatric symptoms with concomitant endocrine abnormalities like diabetes insipidus. \n\u2022 CSF analysis and MRI features should be interpreted in the context of systemic findings (e.g., chest imaging, serum ACE). \n\u2022 Early diagnosis and treatment are essential to prevent permanent neurological sequelae. Recent studies underscore the heterogeneity in the presentation of neurosarcoidosis and highlight the importance of early immunosuppressive therapy to mitigate long-term neurological damage. Corticosteroids remain the cornerstone of treatment, with careful consideration for use in special populations, including pregnant and lactating patients, to balance maternal benefits with fetal safety.",
    "exam_year": "2024",
    "exam_type": "Part I"
  },
  {
    "question": "Patient came from Tanzania, have jaundice, low PLT, anemia, confusion, fever, CSF high lymphocytes, normal glucose what is the most likely diagnosis.",
    "option_a": "P. Falciparum",
    "option_b": "P. Ovale",
    "option_c": "Brucella",
    "option_d": "Meningitis",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "This scenario describes a patient from Tanzania, a malaria\u2010endemic region, who presents with fever, jaundice, anemia, thrombocytopenia, and altered mental status (confusion). These findings are classic for severe Plasmodium falciparum infection (cerebral malaria), as P. falciparum is known for causing multi\u2010organ complications with high mortality. P. falciparum infects red blood cells, leading to their destruction (hemolysis) which causes anemia and jaundice. The infected RBCs also adhere to the vascular endothelium, leading to microvascular occlusion particularly in the brain (cerebral malaria), as well as consumption of platelets resulting in thrombocytopenia. Cerebral involvement can lead to confusion and other neurological deficits. CSF studies in cerebral malaria are generally unremarkable or may show a mild lymphocytic response with normal glucose, helping differentiate it from bacterial meningitis. The combination of a relevant travel history to an endemic area, fever, and circulatory \u2013 as well as neurological \u2013 abnormalities are highly indicative of severe P. falciparum infection. Although a lumbar puncture might be performed to exclude central nervous system infections, normal or near\u2010normal CSF glucose with lymphocytic predominance supports a diagnosis of malaria rather than bacterial meningitis, which typically shows low glucose and neutrophilic pleocytosis. Diagnosis is confirmed with peripheral blood smear (thick and thin films) and rapid diagnostic tests (RDTs) for malaria. Differential diagnoses include viral encephalitis (which can also present with confusion and CSF lymphocytosis) and atypical bacterial meningitis; however, the hemolytic features (jaundice, anemia) and thrombocytopenia strongly favor P. falciparum malaria. Current guidelines recommend prompt initiation of parenteral therapy with intravenous artesunate as the first\u2010line treatment for severe P. falciparum malaria. Supportive management of complications is crucial. In pregnancy, artesunate is preferred over quinine especially in the second and third trimesters, given its superior outcomes and safety profile, while careful monitoring for maternal and fetal well\u2010being is required. If artesunate is not available, quinine with clindamycin may be used. Option A (P. falciparum) is correct. Option B (P. ovale) typically causes a relapsing, more benign form of malaria. Option C (Brucella) is not consistent with the travel history and the hemolytic picture. Option D (Meningitis) is unlikely because bacterial meningitis usually demonstrates a neutrophilic pleocytosis and a low CSF glucose. 1. A history of travel to endemic regions is critical in evaluating febrile illnesses with multi\u2010system involvement. 2. Cerebral malaria may have relatively normal CSF findings despite significant neurological symptoms. 3. Thrombocytopenia is a common laboratory finding in severe malaria. Recent WHO guidelines confirm IV artesunate as the first\u2010line treatment for severe malaria. Emerging research supports early diagnosis and management to reduce mortality and neurological sequelae.",
    "exam_year": "2024",
    "exam_type": "Part I"
  },
  {
    "question": "Patient known case of DM come with black spot on nose management",
    "option_a": "Amphotericin B",
    "option_b": "Fluconazole",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "This scenario describes a patient from Tanzania, a malaria\u2010endemic region, who presents with fever, jaundice, anemia, thrombocytopenia, and altered mental status (confusion). These findings are classic for severe Plasmodium falciparum infection (cerebral malaria), as P. falciparum is known for causing multi\u2010organ complications with high mortality. P. falciparum infects red blood cells, leading to their destruction (hemolysis) which causes anemia and jaundice. The infected RBCs also adhere to the vascular endothelium, leading to microvascular occlusion particularly in the brain (cerebral malaria), as well as consumption of platelets resulting in thrombocytopenia. Cerebral involvement can lead to confusion and other neurological deficits. CSF studies in cerebral malaria are generally unremarkable or may show a mild lymphocytic response with normal glucose, helping differentiate it from bacterial meningitis. The combination of a relevant travel history to an endemic area, fever, and circulatory \u2013 as well as neurological \u2013 abnormalities are highly indicative of severe P. falciparum infection. Although a lumbar puncture might be performed to exclude central nervous system infections, normal or near\u2010normal CSF glucose with lymphocytic predominance supports a diagnosis of malaria rather than bacterial meningitis, which typically shows low glucose and neutrophilic pleocytosis. Diagnosis is confirmed with peripheral blood smear (thick and thin films) and rapid diagnostic tests (RDTs) for malaria. Differential diagnoses include viral encephalitis (which can also present with confusion and CSF lymphocytosis) and atypical bacterial meningitis; however, the hemolytic features (jaundice, anemia) and thrombocytopenia strongly favor P. falciparum malaria. Current guidelines recommend prompt initiation of parenteral therapy with intravenous artesunate as the first\u2010line treatment for severe P. falciparum malaria. Supportive management of complications is crucial. In pregnancy, artesunate is preferred over quinine especially in the second and third trimesters, given its superior outcomes and safety profile, while careful monitoring for maternal and fetal well\u2010being is required. If artesunate is not available, quinine with clindamycin may be used. Option A (P. falciparum) is correct. Option B (P. ovale) typically causes a relapsing, more benign form of malaria. Option C (Brucella) is not consistent with the travel history and the hemolytic picture. Option D (Meningitis) is unlikely because bacterial meningitis usually demonstrates a neutrophilic pleocytosis and a low CSF glucose. 1. A history of travel to endemic regions is critical in evaluating febrile illnesses with multi\u2010system involvement. 2. Cerebral malaria may have relatively normal CSF findings despite significant neurological symptoms. 3. Thrombocytopenia is a common laboratory finding in severe malaria. Recent WHO guidelines confirm IV artesunate as the first\u2010line treatment for severe malaria. Emerging research supports early diagnosis and management to reduce mortality and neurological sequelae.",
    "exam_year": "2024",
    "exam_type": "Part I"
  },
  {
    "question": "Scenario resembling cavernous sinus thrombosis but without proptosis what is dx:",
    "option_a": "Carotid cavernous fistula",
    "option_b": "Thyroid eye?",
    "option_c": "CVT",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "This scenario describes a patient from Tanzania, a malaria\u2010endemic region, who presents with fever, jaundice, anemia, thrombocytopenia, and altered mental status (confusion). These findings are classic for severe Plasmodium falciparum infection (cerebral malaria), as P. falciparum is known for causing multi\u2010organ complications with high mortality. P. falciparum infects red blood cells, leading to their destruction (hemolysis) which causes anemia and jaundice. The infected RBCs also adhere to the vascular endothelium, leading to microvascular occlusion particularly in the brain (cerebral malaria), as well as consumption of platelets resulting in thrombocytopenia. Cerebral involvement can lead to confusion and other neurological deficits. CSF studies in cerebral malaria are generally unremarkable or may show a mild lymphocytic response with normal glucose, helping differentiate it from bacterial meningitis. The combination of a relevant travel history to an endemic area, fever, and circulatory \u2013 as well as neurological \u2013 abnormalities are highly indicative of severe P. falciparum infection. Although a lumbar puncture might be performed to exclude central nervous system infections, normal or near\u2010normal CSF glucose with lymphocytic predominance supports a diagnosis of malaria rather than bacterial meningitis, which typically shows low glucose and neutrophilic pleocytosis. Diagnosis is confirmed with peripheral blood smear (thick and thin films) and rapid diagnostic tests (RDTs) for malaria. Differential diagnoses include viral encephalitis (which can also present with confusion and CSF lymphocytosis) and atypical bacterial meningitis; however, the hemolytic features (jaundice, anemia) and thrombocytopenia strongly favor P. falciparum malaria. Current guidelines recommend prompt initiation of parenteral therapy with intravenous artesunate as the first\u2010line treatment for severe P. falciparum malaria. Supportive management of complications is crucial. In pregnancy, artesunate is preferred over quinine especially in the second and third trimesters, given its superior outcomes and safety profile, while careful monitoring for maternal and fetal well\u2010being is required. If artesunate is not available, quinine with clindamycin may be used. Option A (P. falciparum) is correct. Option B (P. ovale) typically causes a relapsing, more benign form of malaria. Option C (Brucella) is not consistent with the travel history and the hemolytic picture. Option D (Meningitis) is unlikely because bacterial meningitis usually demonstrates a neutrophilic pleocytosis and a low CSF glucose. 1. A history of travel to endemic regions is critical in evaluating febrile illnesses with multi\u2010system involvement. 2. Cerebral malaria may have relatively normal CSF findings despite significant neurological symptoms. 3. Thrombocytopenia is a common laboratory finding in severe malaria. Recent WHO guidelines confirm IV artesunate as the first\u2010line treatment for severe malaria. Emerging research supports early diagnosis and management to reduce mortality and neurological sequelae.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "A woman presented with 5 weeks history of mild psychiatric symptoms (forgot what was is, could be social withdraw and depression + sleep disturbances) on examination she had left homonymous hemi-anopia along with left quadrantanopia color changes and affected MMSE (no other clues mentioned) MRI is normal, what is the most likely diagnosis (vague scenario) going with (Heidenhain variant of cjd)",
    "option_a": "prion disease",
    "option_b": "LBD",
    "option_c": "Tau",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "This scenario describes a patient from Tanzania, a malaria\u2010endemic region, who presents with fever, jaundice, anemia, thrombocytopenia, and altered mental status (confusion). These findings are classic for severe Plasmodium falciparum infection (cerebral malaria), as P. falciparum is known for causing multi\u2010organ complications with high mortality. P. falciparum infects red blood cells, leading to their destruction (hemolysis) which causes anemia and jaundice. The infected RBCs also adhere to the vascular endothelium, leading to microvascular occlusion particularly in the brain (cerebral malaria), as well as consumption of platelets resulting in thrombocytopenia. Cerebral involvement can lead to confusion and other neurological deficits. CSF studies in cerebral malaria are generally unremarkable or may show a mild lymphocytic response with normal glucose, helping differentiate it from bacterial meningitis. The combination of a relevant travel history to an endemic area, fever, and circulatory \u2013 as well as neurological \u2013 abnormalities are highly indicative of severe P. falciparum infection. Although a lumbar puncture might be performed to exclude central nervous system infections, normal or near\u2010normal CSF glucose with lymphocytic predominance supports a diagnosis of malaria rather than bacterial meningitis, which typically shows low glucose and neutrophilic pleocytosis. Diagnosis is confirmed with peripheral blood smear (thick and thin films) and rapid diagnostic tests (RDTs) for malaria. Differential diagnoses include viral encephalitis (which can also present with confusion and CSF lymphocytosis) and atypical bacterial meningitis; however, the hemolytic features (jaundice, anemia) and thrombocytopenia strongly favor P. falciparum malaria. Current guidelines recommend prompt initiation of parenteral therapy with intravenous artesunate as the first\u2010line treatment for severe P. falciparum malaria. Supportive management of complications is crucial. In pregnancy, artesunate is preferred over quinine especially in the second and third trimesters, given its superior outcomes and safety profile, while careful monitoring for maternal and fetal well\u2010being is required. If artesunate is not available, quinine with clindamycin may be used. Option A (P. falciparum) is correct. Option B (P. ovale) typically causes a relapsing, more benign form of malaria. Option C (Brucella) is not consistent with the travel history and the hemolytic picture. Option D (Meningitis) is unlikely because bacterial meningitis usually demonstrates a neutrophilic pleocytosis and a low CSF glucose. 1. A history of travel to endemic regions is critical in evaluating febrile illnesses with multi\u2010system involvement. 2. Cerebral malaria may have relatively normal CSF findings despite significant neurological symptoms. 3. Thrombocytopenia is a common laboratory finding in severe malaria. Recent WHO guidelines confirm IV artesunate as the first\u2010line treatment for severe malaria. Emerging research supports early diagnosis and management to reduce mortality and neurological sequelae.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario of mucormycosis what is the route:",
    "option_a": "direct invasion (through emissary vain)",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Neuro-infectious",
    "explanation": "Mucormycosis is an aggressive fungal infection caused by fungi of the order Mucorales. It typically affects immunocompromised individuals, especially those with uncontrolled diabetes mellitus or diabetic ketoacidosis. The infection usually begins in the nasal turbinates and paranasal sinuses and then spreads locally. The fungi are inhaled as spores, which under high blood sugar and acidic conditions, germinate and invade local tissue. A key feature of mucormycosis is its angioinvasive nature; it invades blood vessel walls causing thrombosis and subsequent tissue necrosis. Although spread can occur via several pathways, the disease classically spreads by direct extension from the infected sinuses to the orbit and brain. The mention of \u2018through emissary vein\u2019 reflects one of the potential routes from extracranial to intracranial spread via valveless venous channels, although direct contiguous invasion remains the hallmark. Patients (often diabetics) present with sinusitis symptoms such as nasal congestion, facial pain, and sometimes black necrotic eschars in the nasal cavity. As the infection spreads, signs of orbital involvement (periorbital edema, vision changes) and even cerebral involvement (altered mental status, focal deficits) may be evident. Differentials include bacterial sinusitis, invasive fungal sinusitis (including aspergillosis), and sometimes neoplastic processes. Diagnosis is based on a combination of imaging (CT or MRI showing bony destruction or soft tissue invasion) and tissue biopsy with histopathologic examination to identify the broad, nonseptate hyphae typical of mucormycosis. Early and aggressive management is crucial. First-line treatment involves a combination of urgent surgical debridement and antifungal therapy typically with liposomal amphotericin B. Second-line or adjunct therapy may include posaconazole or isavuconazole. In patients who are pregnant or lactating, amphotericin B is considered relatively safe (Category B) and is preferred over many azoles, which may have teratogenic risks. Option A \u2013 \u2018direct invasion (through emissary vein)\u2019 \u2013 is correct as it underscores the primary mode of spread in rhinocerebral mucormycosis. Although the wording emphasizes an emissary venous route, which is one of the vascular channels that may permit intracranial extension, the core concept is that the fungus spreads by direct extension from the sinuses to neighboring structures. 1. Rhinocerebral mucormycosis is a rapidly progressive, potentially fatal infection that demands early diagnosis and treatment. 2. Uncontrolled diabetes, particularly in the setting of ketoacidosis, is a major predisposing factor. 3. Treatment requires a combination of surgical debridement and antifungal therapy. Recent guidelines and studies reinforce the importance of early aggressive surgical debridement combined with high-dose liposomal amphotericin B. Newer agents such as posaconazole and isavuconazole are being increasingly considered for salvage or adjunct therapy in cases where amphotericin B is contraindicated or as follow\u2010up therapy.",
    "exam_year": "2020",
    "exam_type": "Part II"
  }
]